Ginkgo Bioworks Holdings, Inc. (DNA) vs Zevra Therapeutics, Inc. (ZVRA)

Ginkgo Bioworks Holdings, Inc. and Zevra Therapeutics, Inc. are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and Zevra Therapeutics, Inc. are of similar size ($683.6M and $668.7M). Ginkgo Bioworks Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Zevra Therapeutics, Inc. trades at 11.6×. Zevra Therapeutics, Inc. grew revenue faster over the last twelve months: 119.4% against −37.0%. Zevra Therapeutics, Inc. has the higher net margin (42.3% vs −219.6%) and the higher return on invested capital (0.00% vs −161.9%). Across the 17 metrics below, Zevra Therapeutics, Inc. leads on 15 and Ginkgo Bioworks Holdings, Inc. on 2.